Introduction Nature always stands first in the healing of various ailments. Many products are available from the various natural sources like the plant, animal, microbial and mineral sources, serving to treat many diseases in humans (Sheetal Verma and Singh, 2008; Katz and Baltz, 2016). Many newly discovered drug molecules serve as excellent medicine for the treatment of chronic illness like cancer, AIDS, tuberculosis etc. About 25% of the drugs prescribed come from the plants (Rates, 2001; Gurnani et al., 2014; Luo et al., 2014; Farnsworth and Morris, 1976; Raskin and Ripoll, 2004), 25% from the animals and 10% from the microbes (Qaralleh, 2016). Many systems of medicine like Ayurveda, Unani, Kampo, Chinese medicine, and Siddha utilizes natural products as the source of the drug, for about 100 decades (Koehn and Carter, 2005; Atanasov et al., 2015). The secondary metabolites from the natural products serve as a base for the development of a large number of drugs (Table I). Drug discovery from natural products has reclaimed attention of the pharmaceutical industry and it is on the Abstract The natural products are the chemical constituents that are generated from the living organism. The natural products are isolated from the plants, animals, and microorganisms which are used in drug design and drug discovery. Natural product is then modified by chemical synthesis as either total or semi-synthetic way. The natural products show various pharmaco- logical activity which can be used for the treatment of a variety of diseases. Natural products could be regarded as a source of quantifiable and chemically pure known products and also natural products can be utilized as complex mixtures subjected to chemical variability. The present review article adds up the prodrugs from natural products as well as prodrugs developed from the natural products. Article Info Received: 6 January 2017 Accepted: 19 April 2017 Available Online: 5 May 2017 DOI: 10.3329/bjp.v12i2.31020 Cite this article: Padmavathy J, Saravanan D. Natural product as a source of prodrug. Bang- ladesh J Pharmacol. 2017; 12: 151-61. A Journal of the Bangladesh Pharmacological Society (BDPS) Bangladesh J Pharmacol 2017; 12: 151-161 Journal homepage: www.banglajol.info Abstracted/indexed in Academic Search Complete, Asia Journals Online, Bangladesh Journals Online, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Current Abstracts, Directory of Open Access Journals, EMBASE/Excerpta Medica, Google Scholar, HINARI (WHO), International Pharmaceutical Abstracts, Open J-gate, Science Citation Index Expanded, SCOPUS and Social Sciences Citation Index; ISSN: 1991-0088 Natural product as a source of prodrug Jagannathan Padmavathy1 and Devarajan Saravanan2 1Department of Pharmaceutics, Jaya College of Paramedical Sciences, College of Pharmacy, CTH Road, Thiruninravur 602024, Chennai, Tamil Nadu, India; 2Department of Pharmaceutical Chemistry, Ratnam Institute of Pharmacy, Pidathapolur, Nellore 524346, Andhra Pradesh, India. M in i-r ev ie w Table I Secondary metabolites from the natural product Metabolite Natural source Artemisinin Artemisia annua Cephalosporin Marine fungi Colchicine Colchicum autumnale Daunomycin Streptomyces clavuligerus Eptifibatide Venom of Southeastern pygmy rattle- snake Ginsenosides Panax quinquefolius Heparin Canine liver cells Insulin Bovine/porcine pancreatic extracts Kainic acid Red algae Lepirudin Saliva of leech Magainin Skin of the frog and toad Paclitaxel Taxus brevifolia Penicillin Penicillium notatum Premarin Pregnant mare’s urine Protamine Salmon fish sperm Triptolide Tripterygium wilfordii This work is licensed under a Creative Commons Attribution 4.0 International License. You are free to copy, distribute and perform the work. You must attribute the work in the manner specified by the author or licensor verge of a comeback due to new technological inputs that promise better returns on investment (Lahlou, 2013; van Herwerden and Sussmuth, 2016). The study in the natural products is on the high score to exploit a variety of lead structures for the development of drugs for the treatment of various diseases (Lahlou, 2007; Siddiqui et al., 2014). As such natural products are important in medicinal sciences and biology for the development of new derivatives of natural drugs, called prodrugs. Prodrugs could occur naturally like numerous botanical constituents or phytoconstituents also endogenous substances, or they could derive from semisynthetic processes or synthetic-designed intentionally during the rational drug design or unintentionally during the drug development. Examples of prodrugs which occur naturally or have been formed unintentionally during the drug development include psilocybin, aspirin, codeine, irinotecan, L-dopa, heroin, and several antiviral nucleosides (Wu, 2009). Various natural products were successfully utilized as prodrugs such as taxol, doxorubicin, morphine, atro- pine, salicin, quinine, prontosil, lovastatin, salicylic acid, digoxin, caffeine etc. in the market (Ovadje et al., 2015). The essential factor related to the identification of natural product based bioactive compounds are currently known. A few natural products are prodrugs that have to be metabolized in vivo by a mammalian organism or intestinal microorganisms to yield the pharmacologically active compounds (Atanasov et al., 2015). In the present scenario, developed and developing countries have started to use the herbal drugs and remedies due to increasing awareness about adverse effects of the modern medicine, which has resulted in the demand for natural products derived prodrugs. Now-a-days, there’s been a renewed interest in studies of prodrugs from the natural product because of the failure of the pharmaceutical drugs in the therapeutic areas like anti-infective, immunosuppressant and meta- bolic diseases due to poor water solubility, severe side effects, and drug specificity. Natural products studies will continue to discover a number of lead structures that can be utilized for templates for the development of new prodrugs in the pharmaceutical industry (Chin et al., 2006). They serve as a source for the development of prodrugs with extended therapeutic activity. Hence, there has been major studies focused on decreasing the impact of the factors and various prodrugs have been developing from the natural products. Prodrugs from Natural Sources The compound which is inactive, but is converted by chemical or enzymatic means to the active drug is prodrug (Zhang et al., 2014; Han and Amidon, 2000). An example of the synthetic prodrugs includes tolmetin prodrug for glycine, bacampicillin prodrug for ampicillin. Prodrug strategy has been used for many years to solve unwanted drug properties (Jana et al., 2010). Prodrug development needs technical skill in handling. The prodrugs are activated enzymatically or chemi- cally. Prodrugs can be used to increase polarity, lipo- philicity, to improve bioavailability and to target specific site (Dahan et al., 2014; Dahan et al., 2012; Stella et al., 2007) and reduction of toxicity (Stella et al., 1985). The prodrugs can also be obtained from the natural sources. Some of the prodrugs of natural origin include romidepsin, butyrin, psilocybin, salvestrols, spiruchos- tatin A, prontosil, melatonin, baicalin, matricin, senno- sides, barbaloin, geniposide, lignans etc (Kumar et al., 2014). In the present work, new research on the prodrugs of natural origin are presented, as they are of much value in the modern world, for the well-being of the humans (Table II). Ginsenosides Ginsenosides (1) are isolated from the Panax quinque- folius. This is a natural product triterpene saponins and steroid glycosides. Ginsenosides are the members of a dammarane family, which consists of a 4-ring and steroid-like structure. All ginsenosides have two or three hydroxyl groups in the carbon 3 and 20. Ginseno- sides are converted into active metabolites like 20(S)- protopanaxadiol Rb1-Rb3, Rc, Rd, Rg3, Rh2, Rs1 (2) with help of human gut bacteria -glycosidase Eubacterium sp. A-44 (Kobashi, 2004). Ginsenosides produced a variety of pharmacological activities such as anti- inflammatory, anti-oxidant, anti-cancer and vasorelaxa- tion (Lee and Kim, 2014; Leung and Wong, 2010). Saikosaponin Saikosaponin is a triterpene saponin glycoside. It has been isolated from the Bupleurum falcatum. Saikosapo- nin (3) is converted into active metabolite prosaiko- genin E1-E3 (4) by human gut bacteria fucosidase, Eubacterium sp. A-44 (Yu et al., 1997). Prosaikogenin E1 152 Bangladesh J Pharmacol 2017; 12: 151-161 1 2 -E3 possesses anti-inflammatory activity. Naringin Naringin (5) is a flavonoid found in the citrus and grapefruits, which produces bitter taste to grape and citrus fruits. Naringin is a prodrug form of naringenin (6). Naringin is metabolized into naringenin via prunin produced by human intestinal bacteria or YK-4 and JY- 6. Naringin and naringenin are very powerful anti- oxidants, in comparison with naringin. Naringenin produces strong anti-oxidant activity due to the pre- sence of sugar moiety in the naringin that causes steric hindrance of the scavenging group (Yu et al., 1997). Resveratrol Resveratrol (7) is natural phenol found in the blue- berries, senna, mulberries, and raspberries and acts as an anti-cancer agent (Li et al., 2015). It is a prodrug form of picea-tannol. Piceatannol (8) is a natural phenol, produced naturally in various plants when the plant is attacked by pathogens such as bacteria or fungi. Resveratrol is metabolized in the body into piceatannol by the enzyme cytochrome P450 (Kukreja et al., 2014; Kim et al., 2009). Ursolic acid Ursolic acid (9) is a pentacyclic triterpenoid present in various plants such as peppermint, rosemary, oregano, lavender, thyme, basil, apples, cranberries, hawthorn and elder. Ursolic acid is a prodrug form of the ursonic acid (10). Ursolic acid is converted into ursonic acid by Aspergillus flavus. In vitro, ursolic acid prevents the expansion or growth of numerous cancer cells inhibiting the STAT3 activation pathway as well as reduces the expansion or growth of cancer cells and stimulates apoptosis (Wang et al., 2011; Jia et al, 2015). Ursolic acid is also found to inhibit JNK expression and IL-2 activation of JURKAT leukemic T Cells, causing a decrease in proliferation, and T cells activation. Esculin Esculin (11) is a naturally occurring coumarin glycoside found in the Aesculus californica, Aesculus hippocastanum, Daphne mezereum, Bursaria spinosa, and dandelion coffee. Table II Prodrugs from natural product Source Prodrugs Bupleurum falcatum Saikosaponin Citrus and grapefruits Naringin Blueberries, senna, mulberries, and raspberries Resveratrol Peppermint, rosemary, oregano, lavender, thyme, basil, apples, cran- berries, hawthorn and elder Ursolic acid Aesculus californica, Aesculus hippo- castanum, Daphne mezereum, Bursaria spinosa and dandelion coffee Esculin Muscle tissue n-Acetylcarnosine Citrus unshiu, Citrus aurantium, Zanthoxylum gilletii, lime, lemon, peppermint and Agathosma serratifo- lia Hesperidin Penicillium citinium Mevastatin Streptomyces Duocarmycins Streptomyces atroolivaceus Leinamycin E1 Soybeans Genistin and dai- dzin Lemon fruit Eriocitrin Hypoxis hemerocallidea Hypoxoside Withania somnifera 2,3-dihydro-3 -O- sulfate withaferin A Streptomyces hygroscopicus Validamycin A Unadulterated wines -Butyro lactone Bergenia crassifolia, wheat and bear- berry Arbutin Horseradish, mustard and cabbage Glucosinolates Garlic Alliin Phaseolus lunatus Linamarin Sambucus Canadensis Prunasin Trifolium repens Amygdalin Zea mays Dhurrin Zamia pumila and Cycas revolute Cycasin Ceratocephalus testiculata Ranunculin Mitochondria Aminolevulinic acid 3 4 5 6 7 8 9 10 Bangladesh J Pharmacol 2017; 12: 151-161 153 Esculin is used for the treatment of fungal infection on the skin. Esculin is a prodrug form of esculetin (12). Esculin is hydrolysed to esculetin in the body through -glucosidases. -glucosidases is produced by dermato- phytes or dermal microbiota (Mercer et al., 2013). Esculitin is a natural lactone, which is a derivative of esculin. Esculetin possesses various pharmacological activities such as an anti-pathogenic, antitumor, anti- inflammatory, and neuroprotective activity (Wang et al., 2015; Tubaro et al., 1988). N-Acetylcarnosine N-Acetylcarnosine is a naturally occurring compound in our body tissues, especially in muscle tissue. It is a free radical scavenger that is structurally related to dipeptide carnosine. N-acetylcarnosine (13) is used for the treatment of cataracts. It is prodrug form of carno- sine. N-acetylcarnosine is converted into biologically active peptide carnosine by the enzyme carnosinase. Carnosine (14) is a dipeptide of the amino acids such as -alanine and histidine. Carnosine scavenges the reac- tive oxygen species and , -unsaturated aldehyde formed from the peroxidation of fatty acids in cell membrane during the oxidative stress (Babizhayev, 2012). Hesperidin Hesperidin (15) is a flavanone glycoside present in Citrus unshiu, Citrus aurantium, Zanthoxylum gilletii, lime, lemon, peppermint and leaves of Agathosma serratifolia. Hesperidin is prodrug form of hesperetin (16). Hesperidin is converted into hesperetin by human intestinal microflora hesperidin 6-O-alpha-L-rhamnosyl -beta-D-glucosidase. Hesperidin cannot prevent the histamine release from RBL-2H3 cells activated by IgE. Hesperetin prevents the histamine release from RBL- 2H3 cells and inhibits cyclooxygenase 2 (Alam et al., 2014; Lee et al., 2004). Mevastatin Mevastatin (17) was isolated from Penicillium citinium. Mevastatin acts as a cholesterol lowering agent, which is a competitive inhibitor of HMG-CoA reductase. HMG-CoA reductase catalyzes the rate-limiting step in the biosynthesis of cholesterol. Mevastatin acts as a pro- drug and is converted into active form in vivo via the hydrolysis of the lactone ring and the hydrolyzed lactone ring resembles the tetrahedral intermediate produced by the enzyme HMG-CoA reductase. Mevas- tatin also acts as an antibacterial and antifungal agent (McFarland et al., 2014; Endo, 1992). Duocarmycins Duocarmycins such as A, B1, B2, C1, C2, D, SA and CC- 1065 are natural prodrugs isolated from the Strepto- myces. Duocarmycins are naturally occurring antitumor agents and are acting as a DNA minor groove binding alkylating agent. Duocarmycins attaches to the minor groove of DNA and alkylates the purine base adenine at N3 position. The alkylation of DNA base disrupts the nucleic acid structure that leads to tumor cell death (Searcey, 2002). Leinamycin E1 Leinamycin E1 is natural prodrug isolated from the Streptomyces atroolivaceus. It is potent antitumor anti- biotic. Leinamycin E1 possesses antitumor activity by the episulfonium ion mediated DNA alkylation. Leina- mycin E1 is oxidatively converted into episulfonium ion intermediate by the reactive oxygen species. Episulfo- nium ion intermediate alkylates the purine base adenine at N3 position. The alkylation of DNA base disrupts the nucleic acid structure that leads to tumor cell death (Huang et al., 2015). Isoflavone glycosides Isoflavone glycosides like genistin and daidzin are present in the soybeans and possess estrogenic activity. Genistin (18) and daidzin (19) are large hydrophilic structures that are not hydrolyzed easily by the intestinal absorptive bacteria. But, genistin and daidzin are hydrolyzed to unconjugated isoflavones such as genistein and daidzein respectively by hydrolytic enzymes produced by intestinal bacteria. Genistein (20) and daidzein (21) are readily absorbed and produce more estrogenic effects compared to genistin and daidzin. Genistein and daidzein enter into circulation after absorption through the intestine and transported 11 12 13 14 15 16 17 18 19 154 Bangladesh J Pharmacol 2017; 12: 151-161 to the liver. In the liver, genistein, and daidzein are conjugated by liver metabolizing enzymes and are converted into more water soluble glucuronidated, glycosylated and sulfated isoflavones (Rafii, 2015). Eriocitrin Eriocitrin (22) is an anti-oxidative flavonoid glycoside present in the lemon fruit. It prevents the oxidative damage by free radicals. Eriocitrin is metabolized to eriodictyol by the intestinal bacteria, Bacteroides uniformis or Bacteroides distasonis and then eriodictyol (23) is converted into 3,4-dihydroxyhydrocinnamic (24) and phloroglucinol (25) by Clostridium butyricum. The eriocitrin metabolites exhibited strong anti-oxidant activity (Miyake et al., 2000). Hypoxoside Hypoxoside (26) is a norlignane glycoside found in the Hypoxis hemerocallidea. Hypoxoside is not absorbed into the blood stream but is converted into biologically active compound agloycone rooperal (27) in the human gut by enzyme -glucosidase, the enzyme which is present in the gastrointestinal tract. Rooperal exhibited various pharmacological activities such as anti-infla- mmatory, analgesic and anti-oxidant activities (Smit et al., 1995). 2,3-Dihydro-3 -O-sulfate withaferin A 2,3-Dihydro-3 -O-sulfate withaferin A (28) is a natural product found in the roots of Withania somnifera. Withania somnifera generally called as ashwagandha, which has been used for so many years in Indian system of medicine to enhance the health conditions for elderly peoples and as a tonic to relieve stress. Ashwa- gandha also exhibited anti-cancer and antiangiogenic activities. 2,3-Dihydro-3 -O-sulfate withaferin A is pharmacologically inactive compound, which is conver- ted into pharmacologically active compound withaferin A (29) in in vivo. Withaferin A acts as an anti-oxidant (Xu et al., 2009). Validamycin A Validamycin A (30) is a fungicide and antibiotic produced by Streptomyces hygroscopicus, which is used as an inhibitor of trehalase. It is used for damping off of cucumbers and used for the control of sheath blight of rice. Validamycin A is a prodrug which is converted into pharmacologically more active compound valido- xylamine A (31). Validoxylamine A is a strong inhibitor of trehalase (Sharma, 2014). –Butyrolactone -Butyrolactone (32) is a naturally occurring substance present in the unadulterated wines and act as a recreational intoxicant. It is prodrug form of -hydroxy butyric acid (33). In human, -butyro lactone is converted into -hydroxy butyric acid by the enzyme lactonase present in the blood (Elliott and Burgess, 2005). Arbutin Arbutin (34) is a glycosylated hydroquinone present in the Bergenia crassifolia, wheat, and bearberry. It is a skin whitening cosmetic ingredient, which acts as a prodrug of the toxic active drug hydroquinone (35). Arbutin is hydrolysed to hydroquinone in the skin by skin bacteria 20 21 26 27 28 29 30 31 32 33 22 23 24 25 Bangladesh J Pharmacol 2017; 12: 151-161 155 like Staphylococcus aureus and Staphylococcus epidermidis (Bang et al., 2008). Hydroquinone is more potent skin lightening agent compared to arbutin. Hydroquinone also exhibited other effects like genotoxicity, nephro- toxicity, and cytotoxicity (Rai and Carpinella, 2006). Glucosinolates Glucosinolates (36) are natural phytocomponents present in the pungent plants like horseradish, mustard, and cabbage. Glucosinolates protect the animals against chemically induced cancer, boosting the anti-oxidant status and induces phase II detoxication enzymes. Glucosinolates are converted into active compound isothiocyanate (37) in the presence of water by the enzyme myrosinase, which is conjugated with conjugating agent glutathione after which it is consecutively metabolized into mercapturic acids. Such metabolites are known as dithiocarbamates (Shapiro et al., 2001). Alliin Alliin (38) is a natural phytoconstituent present in the fresh garlic. It is prodrug form of allicin. Alliin is a cysteine derivative. When the garlic is crushed, the alliin is converted into active compound allicin (39) by alliinase enzyme. Allicin possesses various pharmacolo- gical activities like antiviral, antifungal and antibac- terial activities. Allicin is unstable compound, which is immediately converted into diallyl disulfide (Wink, 2003). Cyanogenic glycosides Cyanogenic glycosides such as linamarin, prunasin, amygdalin, and dhurrin are found in the so many food plants like Phaseolus lunatus, Sambucus canadensis, Trifolium repens and Zea mays. Cyanogenic glycosides are prodrug form of hydrogen cyanide. Cyanogenic glycosides are found in the vacuoles and the - glucosidase enzyme is present in the cytosol of the plants. When the plants are damaged by trampling, mastication, drought and wilting, the cyanogenic glycosides are converted into hydrogen cyanide by the enzyme -glucosidase (Wink, 2003). Cycasin Cycasin (40) is the phytotoxin present in Zamia pumila and Cycas revolute. Cycasin is converted into active compound methylazoxymenthanol (41) by intestinal enzyme -glucosidase, which causes the midzonal coagulative hepatic necrosis, centrilobular and gastrointestinal irritation (Smith et al., 1967). Ranunculin Ranunculin (42) is an unstable glucoside present in the plant Ceratocephalus testiculata. When the plant is wounded, the ranunculin is enzymatically converted into glucose and active compound protoanemonin (43). Protoanemonin produces various adverse effects like paralysis, jaundice, acute hepatitis, vomiting, nausea, spasms and dizziness (Martin et al., 1990). Aminolevulinic acid It is a naturally occurring endogenous metabolite produced in the mitochondria by the condensation of succinyl CoA and glycine by the enzyme amino- levulinic acid. Aminolevulinic acid (44) is used for the treatment of cancer. Conjugation of eight molecules of aminolevulinic acid to produced protoporphyrin IX (45). Aminolevulinic acid is metabolized to active sensitizer protoporphyrin IX into all cells. Protopor- phyrin IX converted into heme by the enzyme ferro- chelatase. Protoporphyrin IX is not immediately conver ted into heme which results in accumulation of proto- porphyrin IX in the cells. The target cells exposed to 34 35 36 37 40 41 42 43 44 45 38 39 156 Bangladesh J Pharmacol 2017; 12: 151-161 light that leads to excitation of photosensitizer and production of reactive oxygen species which produced the cytotoxic effects (Wachowska et al., 2011). Prodrugs Developed from Natural Products Mipsagargin (G-202) Mipsagargin (46) is prodrug form of thapsigargin (47). Thapsigargin is the sesquiterpene lactone present in the plant Thapsia garganica and in the fruits and roots of Mediterranean species. Thapsigargin inhibits Ca2+- ATPase leading to apoptosis and has also been utilized in the treatment of solid tumors, which is activated by PSMA mediated cleavage of an inert masking peptide. Thapsigargin is an inhibitor of sarcoplasmic and endoplasmic reticulum calcium adenosine triphosphate pump protein, which is necessary for cell viability (Andersen et al., 2015). Triptolide prodrug Triptolide (48) is a diterpene triepoxide, isolated from Tripterygium wilfordii. In vitro, triptolide inhibits proliferation and induces apoptosis of various cancer cell lines and in vivo, it prevents the tumor growth and metastases. Triptolide has poor aqueous solubility. To overcome this problem, the disodium phosphono- oxymethyl prodrug of triptolide (49) is designed to target various cancers like pancreatic, breast and prostate cancers (Patil et al., 2015). Betulinic acid Betulinic acid (50) is a pentacyclic triterpenoid found in the bark of Betula pubescens. Betulinic acid is a cancer- fighting phytoconstituent, possessing various other pharmacological activities like anti-inflammatory, antiretroviral and antimalarial activities. Betulinic acid has a very low water solubility and shorter half-life. To overcome these problems, betulinic acid prodrug was formulated with help of multi-arm polyethylene glycol linkers. The betulinic acid prodrug showed more water solubility, high drug loading capacity and excellent in vitro anti-cancer activity (Dai et al., 2014). Sesquiterpene lactones The sesquiterpene lactones (51) are classes of terpenoids possessing various pharmacological activities such as antibacterial, antifungal, antiviral, insecticidal and anti- cancer activities because of the presence of -methylene - -lactone. Sesquiterpene lactones are biologically active and have poor aqueous solubility. Sesquiterpene lactones act as Michael acceptor. To overcome the problems, sesquiterpene lactones prodrugs (52) were formulated with the addition of the amine to the - methylene- -lactone to mask this group from nucleophilic attack as well as to increase solubility (Woods et al., 2013). Scutellarin Scutellarin (53) is a flavone type of phenolic phyto- constituents present in Scutellaria lateriflora and Scutellaria barbata which is poor absorbed. To overcome this problem, ethyl ester, benzyl ester and glycolamide ester of scutellarin prodrugs were synthesized. Glycolamide ester of scutellarin prodrug showed good absorption and stability compared to ethyl ester and benzyl ester prodrugs of scutellarin (Cao et al., 2006). Heroin Heroin (54) is a prodrug form of morphine (55). Heroin acts as an opioid painkiller which is used as a recreational drug for its euphoric effects, anti- diarrhoeal and cough suppressant. Heroin is converted into morphine by deacetylation (Sawynok, 1986). 46 47 50 51 52 53 48 49 Bangladesh J Pharmacol 2017; 12: 151-161 157 Quercetin-3-O-acyl esters Quercitin (56) is a flavonol present in the leaves, vegetables, grains and fruits which are synthesized naturally in plants from phenylalanine. Quercetin acts as an anti-oxidant but is poorly absorbed. In order to enhance the absorption, quercetin-3-O-acyl esters such as quercetin propyl (57) and quercetin butyl esters (58) were prepared as prodrugs. Quercetin propyl and quercetin butyl esters had shown more water solubility and better permeability when compared to quercetin (Montenegro et al., 2007). Psilocybin Psilocybin (59) is a psychedelic substance naturally present in the Psilocybe semilanceata, Psilocybe azurescens and Psilocybe cyanescens. Psilocybin is a prodrug, which is converted into biologically active psilocin (60) by cleavage of phosphoric ester group by alkaline phosphatase in the brain. Psilocin is an agonist of many serotonergic receptors such as 5HT1A, 5HT1D, 5HT2A, and 5HT2C in the brain. Psilocin regulates the motivation and mood (Rautio et al., 2008). Aspirin Aspirin (61) is prodrug form of salicylic acid (62). Salicylic acid is a phenolic acid found in the Willow tree. Aspirin reduces the pain, decreases the production of prostaglandins and thromboxanes, reduces the fever, and prevents blood clotting. Aspirin is converted into biologically active salicylic acid in the stomach (Kastrati et al., 2015). Codeine Codeine (63) is a prodrug form of morphine (64). Morphine is isolated from Papaver somniferum and opium poppy, which acts as narcotic analgesic. Codeine is converted into morphine by CYP2D6 (Smith, 2009). Codeine is widely used for the treatment of mild to moderate pain, diarrhea, and as a cough suppressant. Irinotecan Irinotecan (65) is derived from camptothecin. Campto- thecin is isolated from Camptotheca acuminata. Irino- tecan is used for the treatment of gastric tumors and colonic cancer, which is converted into active 7-ethyl-10 -hydroxycamptothecin (66) by the enzyme carboxyl- esterase (Marsh and Hoskins, 2010). L-Dopa L-Dopa (67) is found in Vicia faba and Mucuna pruriens which are used for the treatment of Parkinson's disease. L-Dopa is converted into active dopamine (68) by the enzyme amino acid decarboxylase (Di Stefano et al., 2011). Vidarabine Vidarabine (69), an antiviral drug that is active against the varicella zoster virus and herpes simplex virus. Spongouridine (70) and spongothymidine (71) were isolated from the Tethya crypta which contains D-ribose 54 55 56 57 58 59 60 61 62 63 64 66 65 158 Bangladesh J Pharmacol 2017; 12: 151-161 67 68 and D-arabinose. Spongouridine and spongothymidine were used as a template for the synthesis of vidarabine (Kijjoa and Sawangwong, 2004). Conclusion Considering the importance of the drugs from the natural sources, a new era has developed in which the allopathic medicines are replaced to a great extent by the herbal medicines. A well-known reason for such a revolution occurring in the field of medicine being the awareness among the people worldwide about the serious side effects occurring due to the use of allo- pathic medicines. On contrary, our nature has blessed us with numerous types of medicines from plants, animals, marine sources and microbes. In the present scenario, prodrugs from natural sources have always been an area of research in the field of pharmacy and medicine. They are gaining more and more importance in the field of novel drug discovery. In the present research work, we have extended the search for the prodrugs from natural sources which mean not only herbs but also from marine, animal, and microbes. This present area provides more scope for the research and development for the treatment of many chronic and fatal diseases like cancer, viral diseases, autoimmune diseases etc. and also for the development of the novel drug dosage forms. We have included around 24 new prodrugs from nature along with 13 prodrugs developed from natural products for impro- ving its physical properties. Furthermore studies are yet to be carried out to develop the dosage forms out of the prodrug which can serve as a boon to the human society. Conflict of Interest All authors have completed the ICMJE uniform disclosure form and declare no support from any organization for the submitted work. Acknowledgement The authors are thankful to the authorities of Ratnam Institute of Pharmacy for providing support to the study and other facilities. References Alam P, Alam A, Anwer MK, Alqasoumi SI. Quantitative estimation of hesperidin by HPTLC in different varieties of citrus peels. Asian Pac J Trop Biomed. 2014; 4: 262-66. Andersen TB, López CQ, Manczak T, Martinez K, Simonsen HT. Thapsigargin: From Thapsia L. to mipsagargin. Mole- cules 2015; 20: 6113-127. Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, Rollinger JM, Schuster D, Breuss JM, Bochkov V, Mihovilovic MD, Kopp B, Bauer R, Dirsch VM, Stuppner H. Discovery and resupply of pharmacologically active plant -derived natural products: A review. Biotechnol Adv. 2015; 33: 1582-614. Babizhayev MA. Bioactivation anti-oxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye- drop formulation: Powerful eye health application technique and therapeutic platform. Drug Test Anal. 2012; 4: 468-85. Bang SH, Han SJ, Kim DH. Hydrolysis of arbutin to hydroquinone by skin bacteria and its effect on anti-oxidant activity. J Cosmet Dermatol. 2008; 7: 189-93. Cao F, Guo JX, Ping QN, Shao Y, Liang J. Ester prodrug of scutellarin: Synthesis, physicochemical property and degra- dation. Yao Xue Xue Bao. 2006; 41: 595-602. Chin YW, Balunas MJ, Chai HB, Kinghorn AD. Drug discovery from natural sources. AAPS J. 2006; 8: E239-53. Dahan A, Khamis M, Agbaria R, Karman R. Targeted prodrugs in oral drug delivery: The modern molecular biopharma- ceutical approach. Expert Opin Drug Deliv. 2012; 9: 1001-13. Dahan A, Zimmermann EM, Shabat SB. Modern prodrug design for targeted oral drug delivery. Molecules 2014; 19: 16489-505. Dai L, Li D, Cheng J, Liu J, Deng LH, Wang LY, Lei JD, He J. Water soluble multi-arm-polyethylene glycol–betulinic acid prodrugs: Design, synthesis, and in vivo effectiveness. Polym Chem. 2014; 5: 5775-83. Elliott S, Burgess V. The presence of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) in alcoholic and non-alcoholic beverages. Forensic Sci Int. 2005; 151: 289- 92. Endo A. The discovery and development of HMG-CoA reduc- tase inhibitors. J Lipid Res. 1992; 33: 1569-82. Farnsworth NR, Morris RW. Higher plants: The sleeping giant of drug development. Am J Pharm Sci Support Public Health. 1976; 148: 46-52. 69 70 71 Bangladesh J Pharmacol 2017; 12: 151-161 159 Gurnani N, Mehta D, Gupta M, Mehta BK. Natural products: Source of potential drugs. Afr J Basic Appl Sci. 2014; 6: 171- 86. Han HK, Amidon GL. Targeted prodrug design for optimized drug delivery. AAPS Pharm Sci. 2000; 2: 48-58. Huang SX, Yun BS, Ma M, Basu HS, Church DR, Ingenhorst G, Huang Y, Yang D, Lohman JR, Tang GL, Ju J, Liu T, Wilding G, Shen B. Leinamycin E1 acting as an anti-cancer prodrug activated by reactive oxygen species. Proc Natl Acad Sci. 2015; 112: 8278-83. Jana S, Mandlekar S, Maratha P. Prodrug design to improve pharmacokinetics and drug delivery properties: Challenges to the discovery scientists. Curr Med Chem. 2010; 17: 3874- 904. Jia Y, Jia Z, Chen J, Zhu H, Cui M. Ursolic acid benzaldehyde chalcone leads to inhibition of cell proliferation and arrests cycle in G1/G0 phase in ovarian cancer. Bangladesh J Pharmacol. 2015; 10: 358-65. Katz L, Baltz RH. Natural product discovery: Past, present, and future. J Int Microbiol Biotechnol. 2016; 43: 155-76. Kim DH, Ahn T, Jung HC, Pan JG, Yun CH. Generation of the human metabolite piceatannol from the anti-cancer preven- tive agent resveratrol bay bacterial cytochrome P450 BM3. Drug Metab Dispos. 2009; 37: 932-36. Kobashi K. Plant glycosides are natural prodrugs: Role of human intestinal flora. J Ginseng Res. 2004; 28: 1-4. Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005; 4: 206-20. Kukreja A, Wadhwa N, Tiwari A. Therapeutic role of resvera- trol and piceatannol in disease prevention. J Blood Disord Transfus. 2014; 5: 1-9. Kumar V, Saravanan D, Kumar B, Jayakumar A. Update on prodrugs from natural products. Asian Pac J Trop Med. 2014; 7: S54-59. Lahlou M. Screening of natural products for drug discovery. Expert Opinion Drug Discov. 2007; 2: 697-705. Lahlou M. The success of natural products in drug discovery. Pharmacol Pharm. 2013; 4: 17-31. Lee CH, Kim JH. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res. 2014; 38: 161-66. Lee NK, Choi SH, Park SH, Park EK, Kim DH. Antiallergic activity of hesperidin is activated by intestinal microflora. Pharmacology 2004; 71: 174-80. Leung KW, Wong AST. Pharmacology of ginsenosides: Litera- ture review. Chin Med. 2010; 5: 20. Li X, Deng Y, Hu J, Wang Z, Xie R, Luo H, Hu, X. Resveratrol overcomes TRAIL resistance in human colon cancer cells. Bangladesh J Pharmacol. 2015; 10: 568-76. Luo Y, Cobb RE, Zhao H. Recent advances in natural product discovery. Curr Opin Biotechnol. 2014; 30: 230-37. Martín ML, San Román L, Domínguez A. In vitro activity of protoanemonin, an antifungal agent. Planta Med. 1990; 56: 66 -69. McFarland AJ, Anoopkumar-Dukie S, Arora DS, Grant GD, McDermott CM, Perkins AV, Davey AK. Molecular mechanisms underlying the effects of statins in the central nervous system. Int J Mol Sci. 2014; 15: 20607-37. Mercer DK, Robertson J, Wright K, Miller L, Smith S, Stewart CS, O’Neil DA. A prodrug approach to the use of coumarins as a potential therapeutics for superficial mycoses. PloS ONE. 2013; 8: 1-7. Miyake Y, Shimoi K, Kumazawa S, Yamamoto K, Kinae N, Osawa T. Identification and anti-oxidant activity of flavonoid metabolites in plasma and urine of eriocitrin- treated rats. J Agric Food Chem. 2000; 48: 3217-24. Montenegro L, Carbone C, Maniscalco C, Lambusta D, Nicolosi G, Ventura CA, Puglisi G. In vitro evaluation of quercetin-3-O-acyl esters as topical prodrugs. Int J Pharm. 2007; 336: 257-62. Ovadje P, Roma A, Steckle M, Nicoletti L, Arnason JT, Pandey S. Advances in the research and development of natural health products as main stream cancer therapeutics. Evid Based Complement Altern Med. 2015; 2015: 1-12. Patil S, Lis LG, Schumacher RJ, Norris BJ, Morgan ML, Cuellar RA, Blazar BR, Suryanarayanan R, Gurvich VJ, Georg GI. Phosphonooxymethyl prodrug of triptolide: Synthesis, physicochemical characterization, and efficacy in human colon adenocarcinoma and ovarian cancer xenografts. J Med Chem. 2015; 58: 9334-44. Qaralleh H. Chemical and bioactive diversities of marine sponge Neopetrosia. Bangladesh J Pharmacol. 2016; 11: 433-52. Rafii F. The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol. Metabilites 2015; 5: 56- 73. Rai M, Carpinella MC. Naturally occurring bioactive com- pounds. Vol 3. India, Elsevier Publisher, 2006, pp 11-12. Raskin I, Ripoll C. Can an apple a day keep the doctor away? Curr Pharm Des. 2004; 10: 3419-29. Rates SMK. Plants as source of drugs. Toxicon 2001; 39: 603-13. Sawynok J. The therapeutic use of heroin: A review of the pharmacological literature. Can J Physiol Pharmacol. 1986; 64: 1-6. Searcey M. Duocarmycins: Natures prodrugs? Curr Pharm Des. 2002; 8: 1375-89. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P. Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: Metabolism and excretion in humans. Cancer Epidemiol Biomarkers Prev. 2001; 10: 501-08. Sharma M. Actinomycetes: Source, identification and their applications. Int J Curr Microbiol App Sci. 2014; 3: 801-32. Sheetal Verma, Singh SP. Current and future status of herbal medicines. Vet World. 2008; 1: 347-50. Siddiqui AA, Iram F, Siddiqui S, Sahu K. Role of natural products in drug discovery process. Int J Drug Dev Res. 2014; 6: 172-204. Smit BJ, Albrecht CF, Liebenberq RW, Kruger PB, Freestone M, Gouws L, Theron E, Bouic PJ, Etsebeth S, Van Jaarsveld PP. A phase 1 triol of hypoxoside as an oral prodrug for cancer 160 Bangladesh J Pharmacol 2017; 12: 151-161 Author Info Devarajan Saravanan (Principal contact) e-mail: saravananpidatha@gmail.com; Phone: +09030195077 Smith DWE, McDaniel EG, Laqueur GL. Role of intestinal microorganisms in determining cycasin toxicity. Exp Biol Med. 1967; 124: 691-97. Stella VJ, Barchardt RT, Hageman MJ, Oliyai R, Maag H, Tilley JW. Prodrugs: Challenges and rewards. Springer, New York, 2007. Stella VJ, Charman WN, Naringrekar VH. Prodrugs: Do they have advantages in clinical practice? Drugs 1985; 29: 455-73. Tubaro A, Del Negro P, Ragazzi E, Zampiron S, Della Loggia R. Anti-inflammatory and peripheral analgesic activity of esculetin. Pharmacol Res Commun. 1988; 20: 83-85. van Herwerden EF, Sussmuth RD. Sources for Leads: Natural products and libraries. Handb Exp Pharmacol. 2016; 232: 91- 123. Wachowska M, Muchowicz A, Firezuk M, Gabrysiak M, Winiarska M, Wanczyk M, Bojarczuk K, Golab J. Aminolevulinic acid (ALA) as a prodrug in photodynamic therapy of cancer. Molecules 2011; 16: 4140-64. Wang J, Lu ML, Dai HL, Zhang SP, Wang HX, Wei N. Esculetin, a coumarin derivative, exerts in vitro and in vivo anti-proliferative activity against hepatocellular carcinoma by initiating a mitochondrial-dependent apoptosis pathway. Braz J Med Biol Res. 2015; 48: 245-53. Wang X, Zhang F, Yang L, Mei Y, Long H, Zhang X, Qimuge- Suyila, SU X. Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo. J Biomed Biotechnol. 2011; 2011: 1-8. Wink M. Evolution of secondary metabolites from an ecologi- cal and molecular phylogenetic perspective. Phytochemistry 2003; 64: 3-19. Woods JR, Mo H, Bieberich AA, Alavanja T, Colby DA. Amino -derivatives of the sesquiterpene lactone class of natural products as prodrugs. Med Chem Commun. 2013; 4: 27-33. Wu KM. A new classification of prodrugs: Regulatory pers- pectives. Pharmaceuticals 2009; 2: 77-81. Xu YM, Marron MT, Seddon E, McLaughlin SP, Ray DT, Whitesell L, Gunatilaka AA. 2,3-dihydrowithaferin A-3beta- O-sulfate, a new potential prodrug of withaferin A from aeroponically grown Withania somnifera. Bioorg Med Chem. 2009; 17: 2210-14. Yu KU, Janq IS, Kang KH, Sung CK, Kim DH. Metabolism of saikosaponin c and naringin by human intestinal bacteria. Arch Pharm Res. 1997; 20: 420-24. Zhang Y, Gao Y, Wen X, Ma H. Current prodrugs strategies for improving oral absorption of nucleoside analogues. Asian J Pharm Sci. 2014; 9: 65-74. Bangladesh J Pharmacol 2017; 12: 151-161 161 Your feedback about this paper 1. Number of times you have read this paper 2. Quality of paper 3. Your comments DatePrinted: This article was downloaded by you on: Jun 26, 2017 Text2: Dropdown3: [Click] Dropdown4: [0]